CUSIP 25461H853DAILY S&P BIOTECLABDQ4 2025
Schedule 13D (activist) & 13G (passive) 5%+ ownership filings
No 13D/13G filings on record yet
Schedule 13D/13G beneficial-ownership filings from 2020–present are ingested from SEC EDGAR. Coverage expands as the backfill and daily crawler run.
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Jump Financial, LLC | 140.8K | $2.97M |
| 2 | Citadel Advisors LLC | 135.8K | $2.86M |
| 3 | Bnp Paribas Financial Markets | 100.1K | $2.11M |
| 4 | Qube Research & Technologies Ltd | 62.8K | $1.32M |
| 5 | Susquehanna International Group, LLP | 43.7K | $921.3K |
| 6 | Gts Securities LLC | 42.5K | $895.3K |
| 7 | Ikarian Capital, LLC | 40.8K | $859.7K |
| 8 | Two Sigma Securities, LLC | 36.2K | $762.1K |
| 9 |
| Tower Research Capital LLC (Trc) |
| 32.6K |
| $685.8K |
| 10 | Jane Street Group, LLC | 32.5K | $683.6K |